Delivery Order SPE2DB20D3101-SPE2DB25FRWT6
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gentamicin 800 mg/20 mL vials totaling $1,791.07. This is a firm fixed-price delivery order under a non-competitive award with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued as a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,704.79 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitively awarded, non-set-aside procurement action. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gentamicin 800 mg/20 mL vials with a ceiling value of $1,120.31 under a firm fixed price contract. The award was made on May 8, 2025, with an ultimate completion date of May 9, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a $10,558.45 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gentamicin pediatric 20 mg/2 mL vials. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a competitively awarded (non-set-aside) procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,286.51, is for the delivery of 4,568,577,972 vials of 800 mg/20 mL Gentamicin, a pharmaceutical product used for treating various bacterial infections. The contract has an ultimate completion date of June 18, 2025 and is not set aside for any specific business type....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, valued at $2,292.52, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gentamicin is a critical antibiotic used in military...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for GENTAMICIN 800 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of February 16, 2024 and a potential value of $3,436.19. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gentamicin Pediatric 20 mg/2 ml vials, with a ceiling value of $2,863.71 and a performance period ending on June 10, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp on May 3, 2025, with an ultimate completion date of May 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This competitively awarded, firm fixed-price contract was executed on July 14, 2025, with an ultimate completion date of July 15, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWT6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,495.84 to AmerisourceBergen Drug Corp for the supply of Gentamicin 800 mg/20 mL vials. This competitively awarded, firm fixed-price contract represents a single delivery order with an ultimate completion date of September 29, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competed openly among qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills diverse pharmaceutical needs across multiple therapeutic domains through DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 9/26/25 |